PE ratio relative to earnings growth — is the valuation justified?
0.29
PEG Ratio
0.29
Growth Rate Source
Good Data Quality5-Year EPS CAGR
Current Price
$153.22
TTM EPS
$5.35
P/E Ratio
28.64
Growth Rate
99.9%
5-Year EPS CAGR
Sector
Healthcare
Medical - Devices
Calculated
8/18/2026
9:43:45 AM
Peer Comparison
Sample Size
3 peers
Industry Median PEG
0.07
25th Percentile
0.07
75th Percentile
3.40
PODD PEG (0.29) vs Industry Median (0.07): 322% premium
Symbol
Company
PEG
P/E
Growth
vs PODD
PEN
Penumbra, Inc.
0.07
78.8
1169.4%
-77%
INSP
Inspire Medical Systems, Inc.
0.07
11.9
175.0%
-76%
DXCM
DexCom, Inc.
3.40
35.1
10.3%
+1086%
How to Interpret PEG Ratio
PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.
PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."
PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.
Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.
